Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Essex Property Trust
ESS
|
+$736M |
| 2 |
ExxonMobil
XOM
|
+$566M |
| 3 |
Navient
NAVI
|
+$526M |
| 4 |
Johnson & Johnson
JNJ
|
+$476M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$445M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$930M |
| 2 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$652M |
| 3 |
LSI
LSI CORPORATION
LSI
|
+$431M |
| 4 |
SLM Corp
SLM
|
+$372M |
| 5 |
Apple
AAPL
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.32% |
| 2 | Technology | 13.29% |
| 3 | Healthcare | 12.21% |
| 4 | Industrials | 11.06% |
| 5 | Energy | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
2926
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.2M | ﹤0.01% |
210,098
+16,848
| +9% | +$325K |
|
2927
Information Services Group
III
$204M
| $4.2M | ﹤0.01% |
872,411
+53,013
| +6% | +$262K |
|
|
FCRE
2928
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
| $4.19M | ﹤0.01% |
68,467
+3,196
| +5% | +$216K |
|
2929
Regional Management Corp
RM
$300M
| $4.19M | ﹤0.01% |
270,537
+7,574
| +3% | +$130K |
|
2930
iShares MSCI UAE ETF
UAE
$322M
| $4.17M | ﹤0.01% |
+200,000
| New | +$4.9M |
|
|
SHLO
2931
DELISTED
Shiloh Industries Inc
SHLO
| $4.16M | ﹤0.01% |
225,341
+12,125
| +6% | +$228K |
|
|
SNOW
2932
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $4.16M | ﹤0.01% |
362,886
+10,970
| +3% | +$124K |
|
|
HNH
2933
DELISTED
Handy & Harman Holdings Ltd.
HNH
| $4.16M | ﹤0.01% |
155,301
-1,377
| -0.9% | -$31.4K |
|
|
CSBK
2934
DELISTED
Clifton Bancorp Inc.
CSBK
| $4.15M | ﹤0.01% |
327,872
+62,139
| +23% | +$740K |
|
|
ARAV
2935
DELISTED
Aravive, Inc. Common Stock
ARAV
| $4.15M | ﹤0.01% |
+24,665
| New | +$4.26M |
|
2936
Harvard Bioscience
HBIO
$28.7M
| $4.14M | ﹤0.01% |
91,108
-1,874
| -2% | -$78.7K |
|
|
BKYF
2937
DELISTED
BK KY FINL CORP
BKYF
| $4.14M | ﹤0.01% |
119,023
+4,504
| +4% | +$157K |
|
2938
Casella Waste Systems
CWST
$5.82B
| $4.13M | ﹤0.01% |
825,024
-1,951
| -0.2% | -$10.2K |
|
2939
Hurco Companies Inc
HURC
$142M
| $4.13M | ﹤0.01% |
146,334
-122
| -0.1% | -$3.34K |
|
|
RSH
2940
DELISTED
RADIOSHACK CORP
RSH
| $4.13M | ﹤0.01% |
4,164,221
-1,166,067
| -22% | -$1.66M |
|
|
MRGE
2941
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $4.12M | ﹤0.01% |
1,816,353
-69,029
| -4% | -$157K |
|
|
OMED
2942
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $4.12M | ﹤0.01% |
176,813
+26,265
| +17% | +$649K |
|
|
TVRD
2943
Tvardi Therapeutics
TVRD
$25M
| $4.12M | ﹤0.01% |
6,719
+4,051
| +152% | +$2.18M |
|
|
XBKS
2944
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $4.12M | ﹤0.01% |
237,851
-195
| -0.1% | -$3.26K |
|
|
STML
2945
DELISTED
Stemline Therapeutics, Inc.
STML
| $4.11M | ﹤0.01% |
280,448
+3,310
| +1% | +$50.7K |
|
|
CTRL
2946
DELISTED
Control4 Corporation
CTRL
| $4.11M | ﹤0.01% |
210,303
+78,358
| +59% | +$1.42M |
|
2947
Akebia Therapeutics
AKBA
$346M
| $4.11M | ﹤0.01% |
+147,874
| New | +$3.56M |
|
2948
Gaia
GAIA
$48.1M
| $4.11M | ﹤0.01% |
534,462
+22,841
| +4% | +$166K |
|
|
DVR
2949
DELISTED
CAL DIVE INTERNATIONAL INC COM
DVR
| $4.1M | ﹤0.01% |
3,104,017
-6,959
| -0.2% | -$10.2K |
|
2950
Nature's Sunshine
NATR
$360M
| $4.1M | ﹤0.01% |
241,365
-51,165
| -17% | -$732K |
|
Similar funds
Vanguard Group's Q2 2014 Portfolio in Review
As of Q2 2014, Vanguard Group held 4,058 positions worth $1.27T, up 6.7% from $1.19T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Vanguard Group's Q2 2014 filing shows 118 new, 2,880 increased, 693 reduced and 93 closed positions. Its largest new stake was Navient: 31,795,005 shares worth $563M. The largest sale was BEAM INC COM STK (DE), an estimated $930M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- Vanguard Group's largest Q2 2014 buy was Navient: 31,795,005 shares worth $563M.
- Vanguard Group added most to Essex Property Trust in Q2 2014, an estimated $736M increase.
- Vanguard Group's biggest Q2 2014 reduction was SLM Corp, cutting an estimated $372M.
- Vanguard Group fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $930M.
- Vanguard Group's ten largest holdings make up 13% of its $1.27T portfolio in Q2 2014.
- Vanguard Group opened 118 new positions and closed 93 in Q2 2014.
- Vanguard Group's portfolio value rose 6.7% quarter-over-quarter to $1.27T.
Based on Vanguard Group's 13F filing for Q2 2014, filed 11 Aug 2014.